Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
Yusuf
S
S
D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D016022:Case-Control Studies; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality*; D004232:Diuretics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality*; D015201:Meta-Analysis as Topic; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic
D002121:Calcium Channel Blockers; D004232:Diuretics; D009543:Nifedipine